SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-017720
Filing Date
2024-06-04
Accepted
2024-06-04 16:51:16
Documents
2
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6087
2 POWER OF ATTORNEY (PUBLIC): POA FEB 2024 doc1.txt EX-24 5565
  Complete submission text file 0001127602-24-017720.txt   13278
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Issuer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ALKERMES 852 WINTER STREET WALTHAM MA 02451
Business Address
Daglio David Angelo Jr. (Reporting) CIK: 0001837109 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35299 | Film No.: 241019015